Stian Knappskog

33.4k total citations
105 papers, 2.6k citations indexed

About

Stian Knappskog is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Stian Knappskog has authored 105 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Oncology, 65 papers in Molecular Biology and 41 papers in Cancer Research. Recurrent topics in Stian Knappskog's work include Cancer-related Molecular Pathways (32 papers), Cancer Genomics and Diagnostics (27 papers) and Epigenetics and DNA Methylation (25 papers). Stian Knappskog is often cited by papers focused on Cancer-related Molecular Pathways (32 papers), Cancer Genomics and Diagnostics (27 papers) and Epigenetics and DNA Methylation (25 papers). Stian Knappskog collaborates with scholars based in Norway, Sweden and United States. Stian Knappskog's co-authors include Per Eystein Lønning, Johan R. Lillehaug, Halfdan Sørbye, Jürgen Geisler, Staffan Welin, Kjell Öberg, Christian Busch, Christian Busch, Ranjan Chrisanthar and Kristian Hveem and has published in prestigious journals such as Nature Communications, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Stian Knappskog

102 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stian Knappskog Norway 29 1.4k 1.3k 757 357 305 105 2.6k
Marc Zapatka Germany 30 1.5k 1.1× 921 0.7× 674 0.9× 264 0.7× 119 0.4× 80 2.6k
Thomas Botton France 12 1.2k 0.8× 821 0.6× 702 0.9× 266 0.7× 167 0.5× 14 2.1k
John F. Lyons United States 32 2.7k 1.9× 1.3k 1.0× 551 0.7× 308 0.9× 276 0.9× 81 4.3k
Sheri L. Holmen United States 28 2.1k 1.5× 784 0.6× 450 0.6× 407 1.1× 168 0.6× 63 3.0k
Kan Lu United States 22 1.9k 1.3× 868 0.7× 1.1k 1.4× 148 0.4× 197 0.6× 38 3.4k
Oscar Krijgsman Netherlands 27 1.4k 0.9× 1.4k 1.1× 757 1.0× 234 0.7× 173 0.6× 63 2.8k
János L. Tanyi United States 36 1.9k 1.3× 1.7k 1.3× 720 1.0× 301 0.8× 193 0.6× 113 3.9k
Kimal Rajapakshe United States 33 2.1k 1.4× 808 0.6× 1.0k 1.3× 174 0.5× 289 0.9× 96 3.2k
Anita Mangia Italy 29 1.4k 0.9× 1.2k 0.9× 797 1.1× 205 0.6× 105 0.3× 108 2.7k
Gulisa Turashvili Canada 29 1.9k 1.3× 1.2k 0.9× 1.4k 1.8× 392 1.1× 234 0.8× 109 3.9k

Countries citing papers authored by Stian Knappskog

Since Specialization
Citations

This map shows the geographic impact of Stian Knappskog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stian Knappskog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stian Knappskog more than expected).

Fields of papers citing papers by Stian Knappskog

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stian Knappskog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stian Knappskog. The network helps show where Stian Knappskog may publish in the future.

Co-authorship network of co-authors of Stian Knappskog

This figure shows the co-authorship network connecting the top 25 collaborators of Stian Knappskog. A scholar is included among the top collaborators of Stian Knappskog based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stian Knappskog. Stian Knappskog is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lønning, Per Eystein, Oleksii Nikolaienko, & Stian Knappskog. (2025). Constitutional Epimutations: From Rare Events Toward Major Cancer Risk Factors?. JCO Precision Oncology. 9(9). e2400746–e2400746. 1 indexed citations
2.
Lønning, Per Eystein, Oleksii Nikolaienko, & Stian Knappskog. (2024). Constitutional BRCA1 Epimutations: A Key for Understanding Basal‐Like Breast and High‐Grade Serous Ovarian Cancer. Human Mutation. 2024(1). 7353984–7353984.
3.
Knappskog, Stian, Tobias Grob, Ursula Amstutz, et al.. (2023). Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine Carcinoma. JCO Precision Oncology. 7(7). e2200336–e2200336. 12 indexed citations
4.
Rahman, Mohummad Aminur, Agnete S. T. Engelsen, Shahin Sarowar, et al.. (2022). Bortezomib abrogates temozolomide-induced autophagic flux through an ATG5 dependent pathway. Frontiers in Cell and Developmental Biology. 10. 10 indexed citations
5.
Deng, Wei, Jürgen Geisler, Stephanie Geisler, et al.. (2022). Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy. Genome Medicine. 14(1). 86–86. 10 indexed citations
6.
Batalini, Felipe, D. Gulhan, Madeline Polak, et al.. (2022). Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers. Clinical Cancer Research. 28(21). 4714–4723. 22 indexed citations
7.
Nikolaienko, Oleksii, Per Eystein Lønning, & Stian Knappskog. (2021). ramr : an R/Bioconductor package for detection of rare aberrantly methylated regions. Bioinformatics. 38(1). 133–140. 2 indexed citations
8.
Perren, Aurel, Geir Olav Hjortland, Anna Sundlöv, et al.. (2020). Mutational Landscape of 109 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms G3. Neuroendocrinology. 110. 2 indexed citations
9.
Pedersen, Line, Stian Knappskog, Per Eystein Lønning, et al.. (2020). Golgi-Localized PAQR4 Mediates Antiapoptotic Ceramidase Activity in Breast Cancer. Cancer Research. 80(11). 2163–2174. 14 indexed citations
10.
Dyrstad, Sissel E., Deusdedit Tusubira, Stian Knappskog, Karl Johan Tronstad, & Gro Vatne Røsland. (2018). Introducing nano-scale quantitative polymerase chain reaction. Biochemical and Biophysical Research Communications. 506(4). 923–926. 6 indexed citations
11.
Gansmo, Liv B., et al.. (2017). The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells. Translational Oncology. 10(5). 806–817. 5 indexed citations
12.
Larionov, Alexey A., Jürgen Geisler, Stian Knappskog, et al.. (2016). Treatment with aromatase inhibitors stimulates the expression of epidermal growth factor receptor-1 and neuregulin 1 in ER positive/HER-2/neu non-amplified primary breast cancers. The Journal of Steroid Biochemistry and Molecular Biology. 165(Pt B). 228–235. 5 indexed citations
13.
Gansmo, Liv B., Lars J. Vatten, Pål Romundstad, et al.. (2016). Associations between the MDM2 promoter P1 polymorphism del1518 (rs3730485) and incidence of cancer of the breast, lung, colon and prostate. Oncotarget. 7(19). 28637–28646. 22 indexed citations
14.
Sveen, Anita, Inger Marie Løes, Sharmini Alagaratnam, et al.. (2016). Intra-individual genetic heterogeneity among liver metastases in metastatic colorectal cancer.. Journal of Clinical Oncology. 34(4_suppl). 555–555. 1 indexed citations
15.
Bjørnslett, Merete, Stian Knappskog, Per Eystein Lønning, & Anne Dørum. (2012). Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers. BMC Cancer. 12(1). 454–454. 10 indexed citations
16.
Straume, Anne Hege, Kristian Løvås, Hrvoje Miletić, et al.. (2012). Elevated levels of the steroidogenic factor 1 are associated with over-expression of CYP19 in an oestrogen-producing testicular Leydig cell tumour. European Journal of Endocrinology. 166(5). 941–949. 12 indexed citations
17.
Lønning, Per Eystein, Ben P. Haynes, Anne Hege Straume, et al.. (2011). Exploring Breast Cancer Estrogen Disposition: The Basis for Endocrine Manipulation. Clinical Cancer Research. 17(15). 4948–4958. 50 indexed citations
18.
Jönsson, Göran, Christian Busch, Stian Knappskog, et al.. (2010). Gene Expression Profiling–Based Identification of Molecular Subtypes in Stage IV Melanomas with Different Clinical Outcome. Clinical Cancer Research. 16(13). 3356–3367. 189 indexed citations
19.
Knappskog, Stian, Stephanie Geisler, Vidar Staalesen, et al.. (2010). Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers. Molecular Cancer. 9(1). 173–173. 26 indexed citations
20.
Knappskog, Stian, Jürgen Geisler, Thomas Arnesen, Johan R. Lillehaug, & Per Eystein Lønning. (2006). A novel type of deletion in the CDKN2A gene identified in a melanoma‐prone family. Genes Chromosomes and Cancer. 45(12). 1155–1163. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc Zapatka Breakdown of academic impact, for papers by Thomas Botton Breakdown of academic impact, for papers by John F. Lyons Breakdown of academic impact, for papers by Sheri L. Holmen Breakdown of academic impact, for papers by Kan Lu Breakdown of academic impact, for papers by Oscar Krijgsman Breakdown of academic impact, for papers by János L. Tanyi Breakdown of academic impact, for papers by Kimal Rajapakshe Breakdown of academic impact, for papers by Anita Mangia Breakdown of academic impact, for papers by Gulisa Turashvili
Rankless by CCL
2026